RWE and Patient-Centered Outcomes
Widespread availability of real-world data has enabled the generation of evidence and insights that benefit patients, providers, plans, and industry. When that evidence reflects patient outcomes, it provides an invaluable perspective on the consumer experience. Explore our real-world evidence (RWE) analyses and guidance to support your strategic decisions.
Webinar: Valuing the Patient Perspective: Patient-Centered HTA
This expert panel will address the challenge of integrating patient perspectives into value assessments, discussing implications for evidence strategy, health equity, caregiver involvement, and downstream impacts on care delivery.
Drug Repurposing: Potential to Expand Rare Disease Treatment
Drug repurposing offers developers an opportunity to bring treatment options to patients at a reduced cost and shortened timelines, although challenges exist.
Limb Loss and Limb Difference: US Prevalence and Impact
Avalere and the Amputee Coalition analyzed claims data to understand the prevalence of limb loss and limb difference and the implications for public policy.
Video: Innovations in Patient-Centricity: How Rare Disease is Leading the Way
In this installment of our 2024 Trends Influencing Rare Disease series, Avalere experts dive into patient centricity trends in rare disease.
After a Rare Disease Diagnosis, Patient Utilization Rises
Healthcare resource utilization increased for Medicare FFS patients following diagnosis of an ill-defined rare disease.
Variation in Autoimmune Payer Mix Drives Channel Strategy
Variation in mix of payer coverage across autoimmune diseases highlights the need for manufacturers to assess patient payer mix to support channels of access.
Video: Quantifying Indirect Burden and Measuring Novel Elements of Value
In the next installment of our 2023 Top Trends in HEOR series, Avalere experts dive into Trend #10: Quantifying Indirect Burden and Measuring Novel Elements of Value
Top HEOR Trends: Quantifying Indirect Burden and Measuring Novel Elements of Value
Avalere experts dive into Trend #10: Quantifying Indirect Burden and Measuring Novel Elements of Value and discuss its evolving nature.
Assessing the Total Economic Burden of Rare Disease
Innovative research methods can be used to measure the total burden of rare disease, including direct medical costs, indirect costs, and overall life impacts.
2023 Top Trends in HEOR: Policy’s Pressure on HEOR
Avalere experts dive into Trend #9: Policy’s Pressure on HEOR and explore implications of recent policy developments on evidence strategies.
Video: Policy’s Pressure on HEOR
In the next installment of our 2023 Top Trends in HEOR series, Avalere experts dive into Trend #9: Policy’s Pressure on HEOR.
2023 Top HEOR Trends: HEOR as a Differentiator vs. Commodity
Avalere experts dive into Trend #8: HEOR as a Differentiator vs. a Commodity and explore the need for tailored evidence generation planning.
Video: HEOR as a Differentiator Versus a Commodity
In the next installment of our 2023 Top Trends in HEOR series, Avalere experts dive into Trend #8: HEOR as a Differentiator Versus a Commodity.
Video: Reevaluating Value Assessment for HEOR in 2023
In the next installment of our 2023 Top Trends in HEOR series, Avalere experts dive into Trend #7: Value Assessment.
Video: Contextualizing AI for HEOR in 2023
In this installment of our 2023 Top Trends in HEOR series, Avalere experts dive into Trend #6: Artificial Intelligence.
Video: Embedding Patient-Centric Principles in Research, Quality, and Care Delivery
In this installment of our 2023 Top Trends in HEOR series, Avalere experts dive into Trend #5, patient engagement and centricity in healthcare decision making.
HEOR Trends: Patient-Centricity
The patient perspective should be incorporated across the care spectrum, including clinical research and drug development, care decisions, outcomes measures, and how value is defined.
2023 Top Trends in Health Economics and Outcomes Research
Avalere identified the top trends in HEOR and key implications for life sciences companies to consider for their 2024 strategic plans.
Video: 2023 Top Trends in Health Economics and Outcomes Research
Avalere identified the top trends in health economics and outcomes research in 2023 and beyond. In this video, Avalere experts dive into a few of the key trends in HEOR that are significantly shaping the landscape.
Video: Spotlight on Avalere’s Evidence and Strategy Practice
Laura Housman, Avalere’s Evidence and Strategy Practice Director, discusses her past experience, trends in real-world evidence, and the role of data in advocating for the patient voice.